Format

Send to

Choose Destination
EBioMedicine. 2019 Oct 21. pii: S2352-3964(19)30650-4. doi: 10.1016/j.ebiom.2019.09.046. [Epub ahead of print]

NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?

Author information

1
Department of Internal Medicine I, Paracelsus Medical University/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria; Institute of Physiology and Pathophysiology, Paracelsus Medical University, 5020 Salzburg, Austria.
2
Institute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Müllner Hauptstrasse 48, 5020 Salzburg, Austria; Cancer Cluster Salzburg, 5020 Salzburg, Austria. Electronic address: d.neureiter@salk.at.

KEYWORDS:

Biliary tract cancer; Chemoresistance; Chemotherapy; Drug efflux transporters; Nrf2; Reactive oxygen species

PMID:
31648982
DOI:
10.1016/j.ebiom.2019.09.046
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center